New roles and opportunities for pharma and device companies dominated the conversation at day 2 of ePharma 2015, on Feb. 25. The need to demonstrate value, in the form of improved medical outcomes, has become clear. Getting there is another story.
Yeah, yeah. Patients first. But the point was made more than once that we need to look at them as people, whole people, not just patients with a particular condition. People aren’t defined by medical conditions, they’re defined by their Netflix queues. Point being, a precision therapy that matches their genome and has great clinical data behind it may still not be the best match for that particular PERSON.
Mobile and Wearables
Mobile: The future is now!
Wearables: The future is later. Apple just pulled mHealth features from its highly anticipated iWatch, according to Zoe Dunn (@zdunnhealth) of Hale Advisors. Other sensor-equipped wearables are inaccurate, inconvenient, or just don’t offer any real breakthrough data.
Personally, I think that wearables will be of clinical utility for certain well-defined high risk patients in the near term. But for a guy like me, well, a wearable isn’t going to tell my doc anything other than I’m a bit fat and like riding bikes. So while the medicalization of wearables is uncertain, I think they will continue to be popular among fitness enthusiasts.
More updates soon from my Calcium colleagues!